Dual-pore protocells with multitasking capacities for simultaneous delivery of therapeutic enzymes and drugs in macrophage depletion therapy

Jorge Parra-Nieto,Alicia Arroyo-Nogales,Diana Marcos-Fernández,Sandra Jimenez-Falcao,Carmen Arribas,Diego Megias,África Gonzalez-Murillo,Manuel Ramírez,Alejandro Baeza

DOI: https://doi.org/10.1039/d4bm00780h

2024-09-03

Biomaterials Science

Abstract:Macrophages are usually present in solid tumors where they participate in tumor progression, angiogenesis, immunosuppression and metastasis. The design of nanocarriers capable to deliver therapeutic agents to specific cell populations has received huge attention in the last decades. However, the capacity of many of these nanosystems to deliver multiple therapeutic agents with very different chemical nature is more limited. Herein, a novel multitasking nanoplatform capable to deliver large macromolecules and cytotoxic drugs to macrophages is presented. This novel nanosystem has exhibited excellent skills to perform simultaneous tasks: macrophage depletion and glucose starvation maintaining the oxygen levels in the tissue. This nanodevice is composed by a dual-pore mesoporous silica core with capacity to house small cytotoxic drugs as doxorubicin or zoledronic acid, and large macromolecules, as glucose oxidase. The external surface of the silica core was coated with a lipid bilayer to avoid the premature release of the housed drugs. Finally, polymeric nanocapsules loaded with catalase were covalently anchored on the outer lipid bilayer, and carboxy-mannose was attached to the exposed side of the nanocapsules to provide selectivity to macrophages. These nanoamblies were able to transport enzymes (Gox and CAT) maintaining their catalytic activity and therefore, to induce glucose starvation keeping the oxygen levels in the tissue thanks to the tandem enzymatic reaction. The capacity of these nanoassemblies to deliver therapeutic agents to macrophages was evaluated both in static and under flow conditions, showing a rapid capture of the nanoparticles by the macrophages and once there, excellent capacity to induce potent macrophage depletion. This strategy can be straightforwardly adapted for the treatment of different malignancies due to the modular nature of this nanoplatform, which can be loaded with different therapeutic agent combinations, paving the way for the development of personalized nanomedicines for diverse types of tumors.

materials science, biomaterials